Vera for Pharma
Security & data control for regulated content
Protecting Intellectual Property and Trial Data
Bringing new medical technology to market is a long and complex process, requiring everyone from the administrative staff to R&D to sales and marketing to follow exacting compliance guidelines. Every day, you’re sharing privileged information, valuable IP, and regulated documents, and depending on the trusted relationships you’ve built outside the firm to maintain that confidentiality.
As pressure to innovate faster and accelerate the approval process mounts, how are you protecting this information as it moves across and beyond your walls? Ensuring data security and compliance around document-centric processes is critical to protecting the future of your business.
Control Regulated Promotional Materials
When drug and treatment information changes continuously, you need tools to manage controlled promotional materials, draft trial documents, and approvals to reduce compliance risk. You also need full audit capabilities to demonstrate who had access to what information, when, and from where.
With Vera, you get the ability to watermark, track, and report on the secure distribution of controlled documents, even after they’ve left your organization. Imagine the ability to verify that only approved parties accessed your files, combined with the knowledge that only approved promotional materials can be seen by customers. Vera gives you total control over your sensitive data, no matter where it’s stored, and the confidence that you can revoke access to files at any time.Request A Demo
Vera Data Security - Meet Vera
At Vera, we’re changing the way companies around the world protect enterprise data by re-thinking how information can be secured. Vera protects data with the strongest encryption, anywhere, on any device, without changing how people work. Take a minute and check out how Vera data security makes it easy to protect any kind of business information, track it after it’s left your control,...more
When sensitive data is compromised, it can not only create risks for patients, but also expose health care providers and device manufacturers to regulatory and business risks.
BitSight Insights Report